Literature DB >> 21593647

Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes.

Juan Cristóbal Gana1, Pamela L Valentino, Veronique Morinville, Constance O'Connor, Simon C Ling.   

Abstract

BACKGROUND AND AIMS: Inadequate evidence to guide the management of children with esophageal varices may lead to variation in care and the provision of poor-quality care to some children. The aims of the study were to describe approaches taken by pediatric gastroenterologists for the management of esophageal varices in children, and to determine the attitudes of children, parents, and physicians toward screening endoscopy for identification of varices.
METHODS: Canadian pediatric gastroenterologists and hepatologists were questioned about their approaches to screening for esophageal varices and therapy to prevent or treat variceal hemorrhage. Consecutive children with portal hypertension and their parents were surveyed about attitudes to screening endoscopy.
RESULTS: Forty-seven of 72 (65%) physicians responded. Seventy percent of respondents screen for esophageal varices in selected children, most using endoscopy (77%). Fifty-eight percent of respondents who screen for varices would provide primary prophylactic treatment. Most would treat an acute variceal bleed with antibiotics, acid suppression, octreotide, and endoscopy within 24 hours (76%) and then secondary prophylaxis with endoscopic variceal ligation (96%) or β-blockers (28%). Among 29 families surveyed, 63% of parents and 50% of patients would agree to screening endoscopy to understand their risk of variceal bleeding and 67% if prophylactic therapy were available. Families were more concerned about the risk of endoscopic adverse events than were gastroenterologists.
CONCLUSIONS: Pediatric gastroenterologists vary in the care they provide for children at risk for esophageal varices and their attitudes toward the role of screening endoscopy differ from that of their patients. Further evidence is required to support practice guidelines that may reduce variation in care and thus improve its quality.

Entities:  

Mesh:

Year:  2011        PMID: 21593647     DOI: 10.1097/MPG.0b013e318213be81

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

Review 1.  Portal hypertension in children.

Authors:  Simon C Ling
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

2.  Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

3.  Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

4.  Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-01-10

5.  Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Luis A Villarroel Del Pino; Alfredo Peña; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24

6.  Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2020-11-06

7.  Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Daniela Gattini; Lorena I Cifuentes; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2020-03-05

8.  Etiology and management of hemorrhagic complications of portal hypertension in children.

Authors:  Alejandro Costaguta; Fernando Alvarez
Journal:  Int J Hepatol       Date:  2012-10-11

9.  Diversity of endoscopy center operations and practice variation across California's safety-net hospital system: a statewide survey.

Authors:  Lukejohn W Day; Taft Bhuket; John M Inadomi; Hal F Yee
Journal:  BMC Res Notes       Date:  2013-06-15

10.  Risk of variceal hemorrhage and pretransplant mortality in children with biliary atresia.

Authors:  Lee M Bass; Wen Ye; Kieran Hawthorne; Daniel H Leung; Karen F Murray; Jean P Molleston; Rene Romero; Saul Karpen; Philip Rosenthal; Kathleen M Loomes; Kasper S Wang; Robert H Squires; Alexander Miethke; Vicky L Ng; Simon Horslen; M Kyle Jensen; Ronald J Sokol; John C Magee; Benjamin L Shneider
Journal:  Hepatology       Date:  2022-04-18       Impact factor: 17.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.